https://orcid.org/0000-0001-5875-6343
Abstract
Multiple myeloma (MM) is the leading lymphoid malignancy with significant racial disparities, stemming from disparities in disease epidemiology, disease biology, treatment utilization and survival. In this review, we highlight important areas of disparities between Black (African descent) and White (European descent) MM patients by summarizing available evidence and suggesting methods to bridge the gap.
This content is only available as a PDF.
2025
